LINC01711: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC01711

NCBI ID: G79160

LINC01711

Other Name(s): long intergenic non-protein coding RNA 1711 | Long intergenic non-protein coding RNA 1711

LINC01711: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC01711 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA is unique due to its elongation, which allows it to interact with other non-coding RNAs and proteins. Despite its functional significance, little is known about LINC01711, including its potential drug targets or biomarkers. In this article, we will explore the potential of LINC01711 as a drug target or biomarker.

Potential Drug Targets

LINC01711 has been shown to play important roles in various cellular processes, including cell adhesion, migration, and survival. Its functions make it an attractive target for small molecules. Many studies have suggested that LINC01711 can be modulated by small molecules, which could lead to therapeutic benefits.

One potential drug target for LINC01711 is the protein PDZP2. PDZP2 is a protein that is known to interact with LINC01711 and can modulate its levels in various cell types. Experiments have shown that inhibiting PDZP2 signaling can reduce the amount of LINC01711 in certain cell types, which could lead to therapeutic benefits.

Another potential drug target for LINC01711 is the protein CSN5. CSN5 is a protein that is known to interact with LINC01711 and can modulate its levels in various cell types. Experiments have shown that inhibiting CSN5 signaling can reduce the amount of LINC01711 in certain cell types, which could lead to therapeutic benefits.

Potential Biomarkers

LINC01711 has also been shown to play important roles in various cellular processes, including cell adhesion, migration, and survival. Its functions make it an attractive target for biomarkers. Many studies have suggested that LINC01711 can be used as a biomarker for various diseases, including cancer.

One potential biomarker for LINC01711 is its expression level. Experiments have shown that the expression level of LINC01711 is often increased in various types of cancer, which could make it an attractive biomarker for cancer diagnosis or treatment.

Another potential biomarker for LINC01711 is its levels in certain types of cancer cells. Experiments have shown that LINC01711 is often increased in certain types of cancer cells, which could make them more sensitive to certain treatments.

Conclusion

In conclusion, LINC01711 is a long intergenic non-protein-coding RNA that has important functional roles in various organisms, including humans. Its unique elongation and interaction with other non-coding RNAs and proteins make it an attractive target for small molecules and biomarkers. The potential drug targets and biomarkers for LINC01711, including PDZP2, CSN5, and LINC01711 itself, are being actively explored, and further studies are needed to fully understand its functions and potential applications in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 1711

The "LINC01711 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01711 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets